Demoralization clinical trials

Explore recruiting demoralization clinical trials.

Recruiting demoralization studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Demoralization trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Psilocybin - a strategy of rapid antidepressant response in depression comorbid with cancer,a randomized double-blind study with the possibility of entering open extension

Czechia

Therapeutic exploratory (Phase II) EU CTIS Study details

PsyPal; Psilocybin Therapy for Psychological Distress in Palliative Patients

Portugal, Czechia, Netherlands, Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Demoralization trials by city

Demoralization in Toronto Demoralization in Vancouver Demoralization in Montreal Demoralization in Calgary Demoralization in Edmonton Demoralization in Ottawa Demoralization in Winnipeg Demoralization in Quebec City Demoralization in Hamilton Demoralization in Kitchener Demoralization in London Demoralization in Halifax Demoralization in New York Demoralization in Los Angeles Demoralization in Chicago Demoralization in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease